No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.2x · 10Y median 0.3x · 6th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T21:58:23.502Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T21:58:23.502Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T21:58:23.502Z. Latest historical point 2026-08-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T21:58:23.502Z. Latest historical point 2026-08-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T21:58:23.502Z. Latest historical point 2026-10-05.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T21:58:23.502Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T21:58:23.502Z. Latest historical point 2026-08-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T21:58:23.502Z. Latest historical point 2026-08-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Stran & Company, Inc. (SWAG) stock was $1.38 as of Oct 6, 2026, 4:00 PM EDT, down 2.82% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -18.8% · 3-year avg +6.4%/yr · 5-year avg -32.1%/yr
Stran & Company, Inc. provides outsourced marketing solutions in the United States, Canada, and Europe.
Advertising Agencies · Quincy, MA
Next Earnings Date
Nov 17, 2026
42 days away
EPS Estimate
0.02
Revenue Est.
$11.23M
Last Quarter Results
EPS
$0.02
vs Estimate
$0.02
Revenue
$33.36M
vs Estimate
$11.23M
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1SWAG | $25.72M | $1.38 | -2.82% | -18.78% | -32.12% | N/A | N/A |
| 2MNY | $29.54M | $0.67 | +0.03% | -53.94% | N/A | N/A | vs SWAG |
| 3LVO | $30.76M | $2.80 | +5.66% | -38.09% | -38.74% | N/A | vs SWAG |
| 4UONEK | $20.16M | $3.50 | +1.74% | -52.71% | -45.66% | -19.34% | vs SWAG |
| 5ANGH | $32.36M | $3.57 | -4.18% | +24.62% | -48.29% | N/A | vs SWAG |
| 6BBGI | $18.19M | $10.07 | -2.89% | +81.10% | -27.90% | -20.70% | vs SWAG |
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$1.38
High
N/A
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.02 | $0.02 | $0.02 | 1 |
| Quarter ending Dec 2026 | $0.02 | $0.02 | $0.02 | 1 |
| Quarter ending Mar 2027 | $0.02 | $0.02 | $0.02 | 1 |
| Quarter ending Jun 2027 | $-0.02 | $-0.02 | $-0.02 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $11.23M | $11.23M | $11.23M | 1 |
| Quarter ending Dec 2026 | $11.23M | $11.23M | $11.23M | 1 |
| Quarter ending Mar 2027 | $12.79M | $12.79M | $12.79M | 1 |
| Quarter ending Jun 2027 | $13.72M | $13.72M | $13.72M | 1 |
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
